消臌软坚丸治疗肝炎肝硬化腹水88例临床观察  

Clinical observation on treating 88 cases of hepatitis cirrhosis ascites with Xiaogu Ruanjian Wan

作　　者：彭喜娜 

机构地区：[1]南阳市中医院,河南南阳473000

出　　处：《中医临床研究》2017年第4期68-69,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:探究消臌软坚丸治疗肝炎肝硬化腹水88例的临床疗效。方法:选取我院2014年3月-2015年6月收治的88例肝炎肝硬化腹水患者,按照患者住院尾号的奇偶数分成观察组和对照组,各44例。观察组在西药治疗的基础上联合消臌软坚丸治疗,对照组予单纯西药治疗,对比两组的临床疗效、治疗前后肝功能指标改善情况。结果:观察组的治疗总有效率为95.45%,明显优于对照组的79.55%,差异具有统计学意义,P<0.05。治疗后,两组肝功能各项指标进行比较,差异均具有统计学意义,P<0.05。结论:肝炎肝硬化腹水经消臌软坚丸治疗,可在较短的时间消退患者的腹水情况,临床疗效较佳,具有重要的临床价值。Objective:Clinical effects of Xiaogu Ruanjian Wan on hepatitis cirrhosis ascites were investigated.Methods:88patients with liver cirrhosis and ascites from March2014to June2015in our hospital were divided into the observation group and control group according to the tail number of hospitalization,44cases in each.The observation group was treated with western medicine plus Xiaogu Ruanjian Wan,and the control group was treated with western medicine alone.The clinical curative effect and the improvement of liver function before and after treatment were compared between groups.The total efficiency in the treatment group was95.45%,significantly better than79.55%in the control group,the difference was statistically significant,P<0.05.After treatment,the liver function in groups were compared,the difference was statistically significant,P<0.05.Conclusion:Treating hepatitis cirrhosis ascites with Xiaogu Ruanjian Wan showed better curative effects,and the ascites of the patients could be dissipated in a short time,with important clinical value.

关 键 词：消臌软坚丸 肝炎肝硬化腹水 临床疗效 

分 类 号：R575.2[医药卫生—消化系统]